Gazyva Prices, Coupons and Patient Assistance Programs
Gazyva (obinutuzumab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Chronic Lymphocytic Leukemia and Follicular Lymphoma.
Gazyva Prices
The cost for Gazyva intravenous solution (25 mg/mL) is around $7,160 for a supply of 40 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Gazyva price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intravenous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 40 milliliters | $178.99 | $7,159.60 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Gazyva Coupons and Rebates
Gazyva offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Gazyva Genentech BioOncology Co-pay Card: Eligible commercially insured patients may pay $5 copay per prescription and receive an annual savings of up to $25,000 per year; for additional information contact the program at 855-692-6729.
| Applies to: | Gazyva |
| Number of uses: | 12 times within calendar year |
Gazyva Genetech BioOncology Co-pay Card Rebate: Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if their pharmacy is unable to process the co-pay card; for additional information contact the program at 855-692-6729.
| Applies to: | Gazyva |
| Number of uses: | One rebate per prescription fill |
Patient Assistance Programs for Gazyva
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: HealthWell Foundation Copay Program
Elligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Gazyva (obinutuzumab) Injection; IV
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Gazyva (obinutuzumab) Injection; IV
Provider: Genentech Access Solutions BioOncology
Elligibility requirements:- Determined case by case
- Based on FPL
- Varies
- Must be treated by US licensed healthcare provider
- Call for most recent medications as the list is subject to change. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
- Gazyva (obinutuzumab) Injection; IV
Provider: Genentech Patient Foundation
Elligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Income Guidelines published on Program Website
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Gazyva (obinutuzumab) Injection; IV
More about Gazyva (obinutuzumab)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- 1 Review
- Drug class: CD20 monoclonal antibodies
- FDA Approval History
